SP
ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ·Healthcare·Biotechnology
$10.03
+3.35%
Mkt Cap $969.20M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (9 analysts)
$25.50
Range $25.00 – $26.00
Implied Upside
+154.4%
Consensus $25.50 vs current $10.03
NASDAQ·Healthcare·Biotechnology
$10.03
+3.35%
Mkt Cap $969.20M
Buy
1
Hold
0
Sell
0
Price Target (9 analysts)
$25.50
Range $25.00 – $26.00
+154.4%
Consensus $25.50 vs current $10.03